M. Docteur AYMERIC BINARD
✨ Profil synthétique
IA · 29/04/2026Le Dr Aymeric Binard est un rhumatologue libéral à Brest, avec une activité de recherche centrée sur les maladies auto-immunes et inflammatoires. Ses publications sur PubMed couvrent des sujets tels que la corticothérapie, les csDMARDs, le syndrome de Sjögren et le lupus. Avec un h-index de 11 et 31 publications, il a une présence significative dans la communauté scientifique.
Expertises présumées
- Rheumatoid Arthritis
- Vasculitis
- Syndrome de Sjögren
- Lupus érythémateux systémique
- Corticothérapie
- csDMARDs
- Maladies auto-immunes
Synthèse automatique à partir des sources publiques (HAL, OpenAlex, theses.fr, ClinicalTrials.gov, FAI²R, ANS). Pas une évaluation clinique. Le médecin peut corriger via son compte.
Diplômes
🎓 DES & spécialité ordinale
- DES Rhumatologie
- Rhumatologie (SM)
🎓 Diplômes
- DE Docteur en médecine
Source : Annuaire Santé ANS (FHIR Practitioner.qualification) · Mises à jour quotidiennes.
Activité de recherche & publications
Source : bases de données publiques (OpenAlex, PubMed).
h-index
11
h articles cités ≥ h fois chacun. Un h de 11 = 11 publications avec 11+ citations.
Citations
478
Publications
31
i10-index
14
Thématiques principales
- Rheumatoid Arthritis Research and Therapies ×10
- Vasculitis and related conditions ×6
- Salivary Gland Disorders and Functions ×5
- Systemic Lupus Erythematosus Research ×4
- Autoimmune and Inflammatory Disorders Research ×4
Affiliations FR : Centre Hospitalier Régional Universitaire de Brest
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Bibliographie
Usefulness of 18F-FDG PET-CT in detecting subclinical arteritis and cancer associated with polymyalgia rheumatica
2026ArticleJoint Bone Spine
Recommendations from the French Societies of Rheumatology and Physical Medicine and Rehabilitation on the non-pharmacological management of knee osteoarthritis
2024ArticleAnnals of Physical and Rehabilitation Medicine
Economic Evaluation of Sequences of Biological Treatments for Patients With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response or Intolerance to Methotrexate in France
2020ArticleValue in Health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Rheumatoid arthritis treated with 6-months of first-line biologic or biosimilar therapy: an updated systematic review and network meta-analysis
2019ArticleInternational Journal of Technology Assessment in Health Care
Baseline laboratory test abnormalities are common in early arthritis but rarely contraindicate methotrexate: Study of three cohorts (ESPOIR, VErA, and Brittany).
2013ArticleSeminars in Arthritis and Rheumatism
Beware man's best friend".
2010ArticleSpine
Does the BAFF dysregulation play a major role in the pathogenesis of systemic lupus erythematosus?
2008ArticleJournal of Autoimmunity
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
Localisation
Adresses géocodées via la Base Adresse Nationale (api-adresse.data.gouv.fr). Précision indicative.
Lieu de consultation
CABINET DU DR AYMERIC BINARD
CABINET DE RHUMATOLOGIE — 252 RUE FRANCIS THOMAS, 29200 Brest
☎ 0298020040Libéral© OpenStreetMap
Tarifs & secteur de conventionnement
Prendre rendez-vous & contact
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Top publications · les plus citées
- 1Is the blood B-cell subset profile diagnostic for Sjogren syndrome?
Annals of the rheumatic diseases · 2009
- 2Epidemiology of Sjögren's syndrome: where are we now?
Clinical and experimental rheumatology · 2007
📚 44 citations🎯 RCR 1.43 - 3Performance of the polymyalgia rheumatica activity score for diagnosing disease flares
Arthritis and rheumatism · 2008
📚 34 citations🎯 RCR 1.05Lire l'abstract Crossref ↓
AbstractObjectiveTo evaluate the effectiveness of the polymyalgia rheumatica activity score (PMR‐AS) in diagnosing disease flares.MethodsRheumatologists prospectively included 89 patients with PMR (mean ± SD age 74.6 ± 6.2 years, mean ± SD disease duration 1.6 ± 2.2 years). At each visit, the rheumatologist assessed disease activity using a visual analog scale (VAS) and recorded whether a disease flare was diagnosed and/or the glucocorticoid dose changed. Overall, 137 visits including 49 pairs (allowing intraindividual comparisons) were available; a disease flare was diagnosed at 32 visits. We evaluated statistical associations linking flare diagnosis to the PMR‐AS, each of its components (VAS, VAS for pain, C‐reactive protein, morning stiffness, and elevation of upper limbs), and changes in these parameters between 2 visits.ResultsAssociations with disease flare diagnosis were strongest for PMR‐AS scores ≥9.35 (agreement 92%, 95% confidence interval [95% CI] 85.8–95.7%, κ = 0.78; sensitivity 96.6%, 95% CI 80.4–99.8; specificity 90.7%, 95% CI 83.2–95.2) and for ΔPMR‐AS scores ≥6.6 (agreement 98%, 95% CI 88.0–99.9%, κ = 0.95; sensitivity 100%, 95% CI 74.7–100; specificity 97.1%, 95% CI 82.9–99.8). Other parameters showed weaker diagnostic performance.ConclusionThis study supplies new evidence that the PMR‐AS is useful for monitoring PMR activity in everyday practice and for managing glucocorticoid tapering. PMR activity changes seem even more relevant than absolute values.
Publications scientifiques (18) — classées par pathologie
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Transversal10
▼
Transversal10
▼- Usefulness of 18F-FDG PET-CT in detecting subclinical arteritis and cancer associated with polymyalgia rheumatica
Joint bone spine · 2026 · Journal Article
Le Madec A, Querellou S, Binard A, Saraux A, et al.
- Recommendations from the French Societies of Rheumatology and Physical Medicine and Rehabilitation on the non-pharmacological management of knee osteoarthritis
Annals of physical and rehabilitation medicine · 2024 · Journal Article
Pers YM, Nguyen C, Borie C, Daste C, et al.
📚 9 cit.🎯 RCR 2.38🩺 Clinique - Staphylococcus capitis chronic non-destructive septic arthritis without orthopedic implant
Medecine et maladies infectieuses · 2016 · Case Reports
Gazeau P, Noury JB, Binard A, Tandé D, et al.
📚 1 cit. - "Beware man's best friend"
Spine · 2010 · Case Reports
Cleuziou C, Binard A, Devauchelle-Pensec V, Héry-Arnaud G, et al.
📚 9 cit.🔬→🩺 Translationnel - Validity of the polymyalgia rheumatica activity score in primary care practice
Annals of the rheumatic diseases · 2009 · Journal Article
Binard A, Lefebvre B, De Bandt M, Berthelot JM, et al.
📚 21 cit.🔬→🩺 Translationnel - Performance of the polymyalgia rheumatica activity score for diagnosing disease flares
Arthritis and rheumatism · 2008 · Journal Article
Binard A, de Bandt M, Berthelot JM, Saraux A, et al.
📚 34 cit.🎯 RCR 1.05🔬→🩺 Translationnel - Right-sided native valve endocarditis revealing adult-onset Still disease
Annals of internal medicine · 2008 · Case Reports
Saraux A, Binard A, Devauchelle-Pensec V, Jobic Y, et al.
📚 7 cit. - Outcome of early monoarthritis: a followup study
The Journal of rheumatology · 2007 · Comparative Study
Binard A, Alassane S, Devauchelle-Pensec V, Berthelot JM, et al.
📚 12 cit.🔬→🩺 Translationnel - BAFF, a newcomer to the lupus party
Lupus · 2007 · Editorial
Binard A, Youinou P
📚 1 cit. - Group B streptococcal arthritis
Joint bone spine · 2006 · Case Reports
Binard A, Devauchelle V, Goulesque K, Jousse S, et al.
📚 8 cit.
Corticothérapie2
▼
Corticothérapie2
▼- Contribution of the polymyalgia rheumatica activity score to glucocorticoid dosage adjustment in everyday practice
The Journal of rheumatology · 2012 · Journal Article
Cleuziou C, Binard A, De Bandt M, Berthelot JM, et al.
📚 24 cit.🔬→🩺 Translationnel - Usefulness of the disease activity scores for polymyalgia rheumatica for predicting glucocorticoid dose changes: a study of 243 scenarios
Arthritis and rheumatism · 2007 · Evaluation Study
Binard A, De Bandt M, Berthelot JM, Saraux A, et al.
📚 23 cit.🔬→🩺 Translationnel
csDMARDs2
▼
csDMARDs2
▼- Economic Evaluation of Sequences of Biological Treatments for Patients With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response or Intolerance to Methotrexate in France
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2020 · Journal Article
Ghabri S, Binard A, Pers YM, Maunoury F, et al.
📚 18 cit.🎯 RCR 1.35 - Baseline laboratory test abnormalities are common in early arthritis but rarely contraindicate methotrexate: study of three cohorts (ESPOIR, VErA, and Brittany)
Seminars in arthritis and rheumatism · 2013 · Journal Article
Le Boëdec M, Marhadour T, Devauchelle-Pensec V, Jousse-Joulin S, et al.
📚 11 cit.🔬→🩺 Translationnel
Sjögren2
▼
Sjögren2
▼- Is the blood B-cell subset profile diagnostic for Sjogren syndrome?
Annals of the rheumatic diseases · 2009 · Evaluation Study
Binard A, Le Pottier L, Devauchelle-Pensec V, Saraux A, et al.
📚 67 cit.🎯 RCR 1.77🔬→🩺 Translationnel - Epidemiology of Sjögren's syndrome: where are we now?
Clinical and experimental rheumatology · 2007 · Editorial
Binard A, Devauchelle-Pensec V, Fautrel B, Jousse S, et al.
📚 44 cit.🎯 RCR 1.43🔬→🩺 Translationnel
Lupus1
▼
Lupus1
▼- Does the BAFF dysregulation play a major role in the pathogenesis of systemic lupus erythematosus?
Journal of autoimmunity · 2008 · Journal Article
Binard A, Le Pottier L, Saraux A, Devauchelle-Pensec V, et al.
📚 33 cit.
Revue / méta-analyse1
▼
Revue / méta-analyse1
▼- Rheumatoid arthritis treated with 6-months of first-line biologic or biosimilar therapy: an updated systematic review and network meta-analysis
International journal of technology assessment in health care · 2019 · Journal Article
Simpson EL, Ren S, Hock ES, Stevens JW, et al.
📚 6 cit.
Revue générale1
▼
Revue générale1
▼- Rheumatoid arthritis treated with 6-months of first-line biologic or biosimilar therapy: an updated systematic review and network meta-analysis
International journal of technology assessment in health care · 2019 · Journal Article
Simpson EL, Ren S, Hock ES, Stevens JW, et al.
📚 6 cit.
